Bright Minds Biosciences (TSE:DRUG) has released an update.
Bright Minds Biosciences has announced a US$35 million non-brokered private placement, offering common shares and pre-funded warrants to support its drug development and operational needs. The shares are priced at US$21.70 each, with the pre-funded warrants available at a slightly lower price. This strategic move aims to boost the company’s research capabilities and strengthen its financial standing in the pharmaceutical sector.
For further insights into TSE:DRUG stock, check out TipRanks’ Stock Analysis page.
